Skip to main content
. 2015 Jan 5;16(1):966–989. doi: 10.3390/ijms16010966

Table 1.

Increased incidence of MDS in pediatric syndromes associated with defective DNA repair.

Process Involved Disease Gene(s) Involved * Incidence of Disease Incidence of MDS in Patients §
DNA damage response and cell cycle checkpoint Li-Fraumeni syndrome [135] TP53 or CHEK2 400 Cases reported 3 Cases reported
DSB repair
Global Ataxia Telangiectasia [136] ATM 1/100,000 to 40,000 Not reported
HR Bloom syndrome [124] BLM, BLAP75/RMI1 1/48,000 4 Cases reported
Rothmund-Thomson syndrome [125,126,127,128] RECQL4 300 Cases reported 4 Cases reported
Werner syndrome [129,130] WRN 1300 Cases reported 6 Cases reported
FA pathway Fanconi anemia [122] FANC(AG) 1/350,000 20.7%
NHEJ Lig4 syndrome [137] LIG4 Few cases reported 1 Case reported
NER Xeroderma Pigmentosa [136] XP 1/250,000 Not reported
Other
Unclear Neurofibromatosis type 1 [138] NF1 1/3500 200–500-Fold increase in children
Shwachman-Diamond syndrome [139,140,141] SBDS 1/50,000 8%–33%
Telomere maintenance Dyskeratosis congenital [142,143,144] DKC1, NOP10, NHP2, TERC, TERT, TINF2 1/1,000,000 4%–5%
Oxidative DNA damage repair Down syndrome [145,146,147] Trisomy 21 1/1000 to 1/650 1/1000 to 1/500

* Genes involved are the genes thought to be directly responsible for the genetic syndrome mentioned in the corresponding “disease” column; § Most of these diseases present themselves in early childhood. The overall incidence of de novo MDS in children is ~1.8–4 per 1,000,000 [148]; Although these diseases are not considered classical DNA repair-deficiency disorders, patients suffering from them have shown either a compromised DNA damage response or increased potential to acquire DNAlesions [139,146,149,150]; Part of this table was published previously in [112].